Strongbridge Biopharma plc
(NASDAQ GS: SBBP)
Rigrodsky Law, P.A. announces that it is investigating Strongbridge Biopharma plc (“Strongbridge”) regarding possible breaches of fiduciary duties and other violations of law related to Strongbridge’s agreement to be acquired by Xeris Pharmaceuticals, Inc. Under the terms of the agreement, Strongbridge's shareholders will receive 0.7840 shares of Xeris Biopharma Holdings, Inc. plus one contingent value right per share.